DMH4

CAS No. 515880-75-8

DMH4( —— )

Catalog No. M33846 CAS No. 515880-75-8

DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 71 In Stock
10MG 102 In Stock
25MG 168 In Stock
50MG 244 In Stock
100MG 360 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DMH4
  • Note
    Research use only, not for human use.
  • Brief Description
    DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
  • Description
    DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    515880-75-8
  • Formula Weight
    400.47
  • Molecular Formula
    C24H24N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CN1CCOCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hao J, et al. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010 Feb 19;5(2):245-53.??
molnova catalog
related products
  • Pazopanib hydrochlor...

    A potent, orally available, pan-VEGFR inhibitor with IC50 of 10, 30, and 47 nM for VEGFR-1, -2, and -3, respectively.

  • PAN-90806

    PAN-90806 (CP-547632, CP547632) is a highly potent, ATP-competitive, orally active VEGFR-2 inhibitor that blocks VEGFR-2 kinase autophosphorylation (IC50=11 nM) and VEGF-induced VEGFR-2 phosphorylation (IC50=5 nM).

  • PKI-166

    PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC50:0.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cancer.